Press release
Clinical Biomarkers Market Size Forecasted To Achieve $52.8 Billion By 2029 With Steady Growth
Clinical Biomarkers
What Is the Clinical Biomarkers Market Size and Projected Growth Rate?
The Clinical Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Clinical Biomarkers Market Size and Projected Growth Rate?
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12670
What Are the Major Segments in the Clinical Biomarkers Market?
The clinical biomarkers market covered in this report is segmented -
1) By Offering: Product, Service
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas
4) By Application: Clinical Diagnostic, Translational Research
5) By End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users
Subsegments:
1) By Product: Diagnostic Kits, Reagents, Assay Kits, Instruments
2) By Service: Biomarker Discovery Services, Analytical Services, Clinical Trial Services, Data Analysis Services
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp
What Are The Driving Clinical Biomarkers Market Evolution?
The surge in cancer cases is projected to push forth the expansion of the clinical biomarker market. Cancer refers to a range of conditions characterized by abnormal cell proliferation and uncontrolled cell growth, which can potentially damage healthy tissues in the body. Clinical biomarkers are crucial in thwarting cancer by facilitating early detection, evaluating risk, and monitoring individuals prone to developing cancer. For example, Cancer Research UK, a cancer research institution based in the UK, estimates a rise in new kidney cancer cases between 2023 and 2025, from approximately 16,300 to around 21,900 by 2038-2040, indicating a 15% increase within this time frame. Thus, the increasing cancer prevalence contributes significantly to the growth of the clinical biomarker market.
Which Firms Dominate The Clinical Biomarkers Market Segments?
Major companies operating in the clinical biomarkers market include Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.
What Trends Are Expected to Dominate the Clinical Biomarkers Market in the Next 5 Years?
The emergence of groundbreaking technological innovations is a major trend capturing attention in the clinical biomarker industry. Numerous premier companies in the clinical biomarker segment are establishing novel technologies to maintain their market stature. For instance, Veravas Inc., a prominent US-based medical product manufacturer, introduced VeraBIND (Biomarker Isolation and N-enrichment for Detection) technology in June 2023. This technology offers an unrivaled, ingenious approach which improves the accuracy of biomarker detection and minimizes the chances of inaccurate positive or negative outcomes across diverse sample types. By leveraging this innovation, clinical laboratories can enhance their diagnostic methods and support early detection of diseases, enabling timely and targeted interventions. Moreover, VeraBIND facilitates the development of faster assays, assuring accuracy and constancy in research, clinical trials, and diagnostic screenings.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report
Which Is The Largest Region In The Clinical Biomarkers Market?
North America was the largest region in the clinical biomakers market in 2024. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Clinical Biomarkers Market?
2. What is the CAGR expected in the Clinical Biomarkers Market?
3. What Are the Key Innovations Transforming the Clinical Biomarkers Industry?
4. Which Region Is Leading the Clinical Biomarkers Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Biomarkers Market Size Forecasted To Achieve $52.8 Billion By 2029 With Steady Growth here
News-ID: 3996875 • Views: …
More Releases from The Business Research Company
Disposable Syringes Market Anticipated To Witness Robust Growth, Surpassing $16. …
The Disposable Syringes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Disposable Syringes Market Size and Its Estimated Growth Rate?
In recent times, there has been a remarkable growth in the size of the disposable syringes market. The market's worth is projected…
Enterprise Architecture Tools Market Size Forecasted To Achieve $1.83 Billion By …
The Enterprise Architecture Tools Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Enterprise Architecture Tools Market Size and Projected Growth Rate?
The market size for enterprise architecture tools has been increasing consistently over the past few years. The growth is set to continue…
Fast Food Boom Fueling Growth In The Constipation Treatment Market: A Significan …
The Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Constipation Treatment Market Size and Projected Growth Rate?
The Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report…
Nourishing Encapsulated Flavors And Fragrances Market Expansion Through The Food …
The Encapsulated Flavors And Fragrances Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Encapsulated Flavors And Fragrances Market Size and Projected Growth Rate?
Significant growth in the market size is being seen for encapsulated flavors and fragrances in recent years. The market is…
More Releases for Biomarker
Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF (including full…
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the…
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period.
A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis…
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core…
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports.
The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and…
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological…
